Proteomic identification of plasma biomarkers in uterine leiomyoma

Molecular BioSystems

Volumn 8, Issue 4, 2012, Pages 1136-1145

  Lin, Chao Po ^a,b   Chen, Yi Wen ^c   Liu, Wen Hsin ^a   Chou, Hsiu Chuan ^c   Chang, Yi Ping ^a   Lin, Szu Ting ^c   Li, Ji Min ^c   Jian, Shiou Fen ^d   Lee, Ying Ray ^a   Chan, Hong Lin ^c  

^a CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^d Health Science and Management   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; BIOLOGICAL MARKER; CARBONATE DEHYDRATASE; GELSOLIN; HEMOPEXIN; PLASMA PROTEIN; PROTEOME; TRANSFERRIN; VITAMIN D BINDING PROTEIN;

ADULT; ARTICLE; BLOOD; CHEMISTRY; FEMALE; HUMAN; LEIOMYOMA; MASS SPECTROMETRY; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PLASMA; PROTEOMICS; REPRODUCIBILITY; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

ADULT; APOLIPOPROTEIN A-I; BIOLOGICAL MARKERS; BLOOD PROTEINS; CARBONIC ANHYDRASES; FEMALE; GELSOLIN; HEMOPEXIN; HUMANS; LEIOMYOMA; MIDDLE AGED; PLASMA; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSFERRIN; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; VITAMIN D-BINDING PROTEIN;

EID: 84863229828     PISSN: 1742206X     EISSN: 17422051     Source Type: Journal    
DOI: 10.1039/c2mb05453a     Document Type: Article

References (41)

1. V. C. Buttram, Jr. R. C. Reiter Uterine leiomyomata: etiology, symptomatology, and management Fertil. Steril. 1981 36 433 445 (Pubitemid 11027013)
2. A. H. Ligon C. C. Morton Leiomyomata: heritability and cytogenetic studies Hum. Reprod. Update 2001 7 8 14 (Pubitemid 32111961)
3. K. Vu D. L. Greenspan T. C. Wu H. A. Zacur R. J. Kurman Cellular proliferation, estrogen receptor, progesterone receptor, and bcl-2 expression in GnRH agonist-treated uterine leiomyomas Hum. Pathol. 1998 29 359 363 (Pubitemid 28231900)
4. W. S. Ahn K. W. Kim S. M. Bae J. H. Yoon J. M. Lee S. E. Namkoong J. H. Kim C. K. Kim Y. J. Lee Y. W. Kim Targeted cellular process profiling approach for uterine leiomyoma using cDNA microarray, proteomics and gene ontology analysis Int. J. Exp. Pathol. 2003 84 267 279 (Pubitemid 38221805)
5. H. L. Huang H. W. Hsing T. C. Lai Y. W. Chen T. R. Lee H. T. Chan P. C. Lyu C. L. Wu Y. C. Lu S. T. Lin C. W. Lin C. H. Lai H. T. Chang H. C. Chou H. L. Chan Trypsin-induced proteome alteration during cell subculture in mammalian cells J. Biomed. Sci. 2010 17 36
6. T. C. Lai H. C. Chou Y. W. Chen T. R. Lee H. T. Chan H. H. Shen W. T. Lee S. T. Lin Y. C. Lu C. L. Wu H. L. Chan Secretomic and Proteomic Analysis of Potential Breast Cancer Markers by Two-Dimensional Differential Gel Electrophoresis J. Proteome Res. 2010 9 1302 1322
7. H. L. Chan S. Gharbi P. R. Gaffney R. Cramer M. D. Waterfield J. F. Timms Proteomic analysis of redox- and ErbB2-dependent changes in mammary luminal epithelial cells using cysteine- and lysine-labelling two-dimensional difference gel electrophoresis Proteomics 2005 5 2908 2926 (Pubitemid 41059768)
8. Y. W. Chen H. C. Chou P. C. Lyu H. S. Yin F. L. Huang W. S. Chang C. Y. Fan I. F. Tu T. C. Lai S. T. Lin Y. C. Lu C. L. Wu S. H. Huang H. L. Chan Mitochondrial proteomics analysis of tumorigenic and metastatic breast cancer markers Funct. Integr. Genomics 2011 11 225 239
9. H. C. Chou Y. W. Chen T. R. Lee F. S. Wu H. T. Chan P. C. Lyu J. F. Timms H. L. Chan Proteomics study of oxidative stress and Src kinase inhibition in H9C2 cardiomyocytes: A cell model of heart ischemia reperfusion injury and treatment Free Radical Biol. Med. 2010 49 96 108
10. P. H. Hung Y. W. Chen K. C. Cheng H. C. Chou P. C. Lyu Y. C. Lu Y. R. Lee C. T. Wu H. L. Chan Plasma proteomic analysis of the critical limb ischemia markers in diabetic patients with hemodialysis Mol. BioSyst. 2011 7 1990 1998
11. Y. W. Chen J. Y. Liu S. T. Lin J. M. Li S. H. Huang J. Y. Chen J. Y. Wu C. C. Kuo C. L. Wu Y. C. Lu Y. H. Chen C. Y. Fan P. C. Huang C. H. Law P. C. Lyu H. C. Chou H. L. Chan Proteomic analysis of gemcitabine-induced drug resistance in pancreatic cancer cells Mol. BioSyst. 2011 7 3065 3074
12. S. L. Lin J. S. Wang C. S. Huang H. H. Tseng Primary intracerebral leiomyoma: a case with eosinophilic inclusions of actin filaments Histopathology 1996 28 365 369 (Pubitemid 26141731)
13. M. D. Perez-Montiel J. A. Plaza H. Dominguez-Malagon S. Suster Differential expression of smooth muscle myosin, smooth muscle actin, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue Am. J. Dermatopathol. 2006 28 105 111 (Pubitemid 44270869)
14. R. J. Marshall S. G. Braye alpha-1-Antitrypsin, alpha-1-antichymotrypsin, actin, and myosin in uterine sarcomas International Journal of Gynecological Pathology 1985 4 346 354 (Pubitemid 16175333)
15. H. Dieplinger D. P. Ankerst A. Burges M. Lenhard A. Lingenhel L. Fineder H. Buchner P. Stieber Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer Cancer Epidemiol., Biomarkers Prev. 2009 18 1127 1133
16. D. Jackson R. A. Craven R. C. Hutson I. Graze P. Lueth R. P. Tonge J. L. Hartley J. A. Nickson S. J. Rayner C. Johnston B. Dieplinger M. Hubalek N. Wilkinson T. J. Perren S. Kehoe G. D. Hall G. Daxenbichler H. Dieplinger P. J. Selby R. E. Banks Proteomic profiling identifies afamin as a potential biomarker for ovarian cancer Clin. Cancer Res. 2007 13 7370 7379
17. D. H. Jeong H. K. Kim A. E. Prince D. S. Lee Y. N. Kim J. Han K. T. Kim Plasma proteomic analysis of patients with squamous cell carcinoma of the uterine cervix J. Gynecol. Oncol. 2008 19 173 180
18. D. J. Rader Regulation of reverse cholesterol transport and clinical implications Am. J. Cardiol. 2003 92 42J 49J
19. Y. T. Chen C. L. Chen H. W. Chen T. Chung C. C. Wu C. D. Chen C. W. Hsu M. C. Chen K. H. Tsui P. L. Chang Y. S. Chang J. S. Yu Discovery of novel bladder cancer biomarkers by comparative urine proteomics using iTRAQ technology J. Proteome Res. 2010 9 5803 5815
20. P. Kelly V. Appleyard K. Murray F. Paulin D. Lamont L. Baker S. Suttie D. Exon A. Thompson Detection of oesophageal cancer biomarkers by plasma proteomic profiling of human cell line xenografts in response to chemotherapy Br. J. Cancer 2010 103 232 238
21. X. Wang S. Dai Z. Zhang L. Liu J. Wang X. Xiao D. He B. Liu Characterization of apolipoprotein A-I as a potential biomarker for cholangiocarcinoma Eur. J. Cancer Care 2009 18 625 635
22. K. R. Kozak F. Su J. P. Whitelegge K. Faull S. Reddy R. Farias-Eisner Characterization of serum biomarkers for detection of early stage ovarian cancer Proteomics 2005 5 4589 4596 (Pubitemid 41739936)
23. M. Tachibana Y. Ohkura Y. Kobayashi H. Sakamoto Y. Tanaka J. Watanabe K. Amikura Y. Nishimura K. Akagi Expression of apolipoprotein A1 in colonic adenocarcinoma Anticancer Res. 2003 23 4161 4167 (Pubitemid 37474914)
24. P. K. Chong H. Lee J. Zhou S. C. Liu M. C. Loh J. B. So K. H. Lim K. G. Yeoh Y. P. Lim Reduced plasma APOA1 level is associated with gastric tumor growth in MKN45 mouse xenograft model J. Proteomics 2010 73 1632 1640
25. Q. Guo B. Zhang X. Dong Q. Xie E. Guo H. Huang Y. Wu Elevated levels of plasma fibrinogen in patients with pancreatic cancer: possible role of a distant metastasis predictor Pancreas 2009 38 e75 e79
26. H. Takeuchi S. Ikeuchi Y. Kitagawa A. Shimada T. Oishi Y. Isobe K. Kubochi M. Kitajima S. Matsumoto Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus J. Gastroenterol. Hepatol. 2007 22 2222 2227 (Pubitemid 350145609)
27. E. Camerer A. A. Qazi D. N. Duong I. Cornelissen R. Advincula S. R. Coughlin Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis Blood 2004 104 397 401 (Pubitemid 38900020)
28. C. A. Staton N. J. Brown C. E. Lewis The role of fibrinogen and related fragments in tumour angiogenesis and metastasis Expert Opin. Biol. Ther. 2003 3 1105 1120 (Pubitemid 37295766)
29. J. S. Palumbo J. L. Degen Fibrinogen and tumor cell metastasis Haemostasis 2001 31 suppl. 1 11 15
30. N. Walsh P. Dowling N. O'Donovan M. Henry P. Meleady M. Clynes Aldehyde dehydrogenase 1A1 and gelsolin identified as novel invasion-modulating factors in conditioned medium of pancreatic cancer cells J. Proteomics 2008 71 561 571
31. M. Sanchez-Carbayo N. D. Socci L. Richstone M. Corton N. Behrendt J. Wulkfuhle B. Bochner E. Petricoin C. Cordon-Cardo Genomic and proteomic profiles reveal the association of gelsolin to TP53 status and bladder cancer progression Am. J. Pathol. 2007 171 1650 1658 (Pubitemid 350158325)
32. J. Yang N. Ramnath K. B. Moysich H. L. Asch H. Swede S. J. Alrawi J. Huberman J. Geradts J. S. Brooks D. Tan Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer BMC Cancer 2006 6 203
33. M. Habeck Gelsolin: a new marker for breast cancer? Mol. Med. Today 1999 5 503
34. J. D. Andersen K. L. Boylan R. Jemmerson M. A. Geller B. Misemer K. M. Harrington S. Weivoda B. A. Witthuhn P. Argenta R. I. Vogel A. P. Skubitz Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients Journal of Ovarian Research 2010 3 21
35. T. Kakisaka T. Kondo T. Okano K. Fujii K. Honda M. Endo A. Tsuchida T. Aoki T. Itoi F. Moriyasu T. Yamada H. Kato T. Nishimura S. Todo S. Hirohashi Plasma proteomics of pancreatic cancer patients by multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis (2D-DIGE): up-regulation of leucine-rich alpha-2-glycoprotein in pancreatic cancer J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2007 852 257 267 (Pubitemid 46830120)
36. B. K. Kim J. W. Lee P. J. Park Y. S. Shin W. Y. Lee K. A. Lee S. Ye H. Hyun K. N. Kang D. Yeo Y. Kim S. Y. Ohn D. Y. Noh C. W. Kim The multiplex bead array approach to identifying serum biomarkers associated with breast cancer Breast Cancer Res. 2009 11 R22
37. K. Bijian A. M. Mlynarek R. L. Balys S. Jie Y. Xu M. P. Hier M. J. Black M. R. Di Falco S. LaBoissiere M. A. Alaoui-Jamali Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment J. Proteome Res. 2009 8 2173 2185
38. B. Chatterji J. Borlak Serum proteomics of lung adenocarcinomas induced by targeted overexpression of c-raf in alveolar epithelium identifies candidate biomarkers Proteomics 2007 7 3980 3991 (Pubitemid 350100013)
39. L. M. Brown S. M. Helmke S. W. Hunsucker R. T. Netea-Maier S. A. Chiang D. E. Heinz K. R. Shroyer M. W. Duncan B. R. Haugen Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue Mol. Carcinog. 2006 45 613 626 (Pubitemid 44205101)
40. H. L. Chan S. Gharbi P. R. Gaffney R. Cramer M. D. Waterfield J. F. Timms Proteomic analysis of redox- and ErbB2-dependent changes in mammary luminal epithelial cells using cysteine- and lysine-labelling two-dimensional difference gel electrophoresis Proteomics 2005 5 2908 2926 (Pubitemid 41059768)
41. D. S. Dalpathado H. Desaire Glycopeptide analysis by mass spectrometry Analyst 2008 133 731 738 (Pubitemid 351720859)